GB0018656D0 - Pharmaceutically active compounds - Google Patents

Pharmaceutically active compounds

Info

Publication number
GB0018656D0
GB0018656D0 GB0018656A GB0018656A GB0018656D0 GB 0018656 D0 GB0018656 D0 GB 0018656D0 GB 0018656 A GB0018656 A GB 0018656A GB 0018656 A GB0018656 A GB 0018656A GB 0018656 D0 GB0018656 D0 GB 0018656D0
Authority
GB
United Kingdom
Prior art keywords
active compounds
pharmaceutically active
pharmaceutically
compounds
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0018656A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0018656A priority Critical patent/GB0018656D0/en
Publication of GB0018656D0 publication Critical patent/GB0018656D0/en
Priority to TW089118861A priority patent/TWI265925B/en
Priority to US09/685,080 priority patent/US6677335B1/en
Priority to MYPI20004712A priority patent/MY130319A/en
Priority to PH12000002783A priority patent/PH12000002783B1/en
Priority to EG20001281A priority patent/EG24411A/en
Priority to GT200000171A priority patent/GT200000171A/en
Priority to TNTNSN00199A priority patent/TNSN00199A1/en
Priority to PA20008504501A priority patent/PA8504501A1/en
Priority to AU76784/00A priority patent/AU779065B2/en
Priority to CO00077467A priority patent/CO5251477A1/en
Priority to DE60016615T priority patent/DE60016615T2/en
Priority to DK00966347T priority patent/DK1220856T3/en
Priority to PL00357536A priority patent/PL357536A1/en
Priority to ES00966347T priority patent/ES2232502T3/en
Priority to EEP200200195A priority patent/EE05181B1/en
Priority to CA002387357A priority patent/CA2387357C/en
Priority to EA200200337A priority patent/EA004982B1/en
Priority to HU0203450A priority patent/HUP0203450A3/en
Priority to GEAP20005578A priority patent/GEP20033068B/en
Priority to DZ003220A priority patent/DZ3220A1/en
Priority to PCT/IB2000/001457 priority patent/WO2001027113A2/en
Priority to JP2001530331A priority patent/JP3834236B2/en
Priority to BR0014698-6A priority patent/BR0014698A/en
Priority to APAP/P/2002/002456A priority patent/AP1238A/en
Priority to OA1200200104A priority patent/OA12061A/en
Priority to SV2000000195A priority patent/SV2002000195A/en
Priority to CNB2004100384099A priority patent/CN100383141C/en
Priority to KR1020027004643A priority patent/KR100549152B1/en
Priority to SK460-2002A priority patent/SK4602002A3/en
Priority to PE2000001090A priority patent/PE20010737A1/en
Priority to AT00966347T priority patent/ATE284404T1/en
Priority to IL14902600A priority patent/IL149026A0/en
Priority to NZ518078A priority patent/NZ518078A/en
Priority to CNB2005100625827A priority patent/CN100378100C/en
Priority to TR2002/00989T priority patent/TR200200989T2/en
Priority to GEAP20006408A priority patent/GEP20033142B/en
Priority to YUP-314/02A priority patent/RS50476B/en
Priority to CZ20021158A priority patent/CZ20021158A3/en
Priority to CNB008151954A priority patent/CN1204138C/en
Priority to PT00966347T priority patent/PT1220856E/en
Priority to SI200030593T priority patent/SI1220856T1/en
Priority to EP00966347A priority patent/EP1220856B1/en
Priority to AU7269001A priority patent/AU7269001A/en
Priority to CA002417264A priority patent/CA2417264C/en
Priority to AT01951842T priority patent/ATE286901T1/en
Priority to KR20037001202A priority patent/KR100457937B1/en
Priority to EA200300079A priority patent/EA004681B1/en
Priority to CNB018133924A priority patent/CN1207297C/en
Priority to BR0112734-9A priority patent/BR0112734A/en
Priority to MXPA03000856 priority patent/MX233602B/en
Priority to NZ523226A priority patent/NZ523226A/en
Priority to PCT/IB2001/001280 priority patent/WO2002010171A1/en
Priority to JP2002515900A priority patent/JP2004505087A/en
Priority to ES01951842T priority patent/ES2231521T3/en
Priority to EP01951842A priority patent/EP1305314B1/en
Priority to GE5062A priority patent/GEP20053494B/en
Priority to IL15322601A priority patent/IL153226A0/en
Priority to HU0302982A priority patent/HUP0302982A3/en
Priority to PL01365133A priority patent/PL365133A1/en
Priority to OA1200300008A priority patent/OA12337A/en
Priority to CZ2003126A priority patent/CZ2003126A3/en
Priority to UA2003010715A priority patent/UA72631C2/en
Priority to DE60108398T priority patent/DE60108398T2/en
Priority to SK57-2003A priority patent/SK572003A3/en
Priority to PT01951842T priority patent/PT1305314E/en
Priority to SI200130283T priority patent/SI1305314T1/en
Priority to EEP200300045A priority patent/EE200300045A/en
Priority to AU2001272690A priority patent/AU2001272690B2/en
Priority to DZ013364A priority patent/DZ3364A1/en
Priority to YU4703A priority patent/YU4703A/en
Priority to DK01951842T priority patent/DK1305314T3/en
Priority to PE2001000746A priority patent/PE20020277A1/en
Priority to MYPI20013530A priority patent/MY117831A/en
Priority to US09/915,705 priority patent/US6420557B1/en
Priority to PH12001001922A priority patent/PH12001001922B1/en
Priority to UY26854A priority patent/UY26854A1/en
Priority to DO2001000217A priority patent/DOP2001000217A/en
Priority to APAP/P/2001/002234A priority patent/AP1400A/en
Priority to ARP010103576A priority patent/AR032628A1/en
Priority to PA20018523501A priority patent/PA8523501A1/en
Priority to TNTNSN01112A priority patent/TNSN01112A1/en
Priority to SV2001000570A priority patent/SV2001000570A/en
Priority to TW090118441A priority patent/TWI285643B/en
Priority to CU20020060A priority patent/CU23198A3/en
Priority to IS6320A priority patent/IS2181B/en
Priority to IN385MU2002 priority patent/IN2002MU00385A/en
Priority to MA26586A priority patent/MA26825A1/en
Priority to CR6617A priority patent/CR6617A/en
Priority to IL149026A priority patent/IL149026A/en
Priority to NO20021694A priority patent/NO322856B1/en
Priority to MXPA02003627 priority patent/MX228340B/en
Priority to HR20020317A priority patent/HRP20020317B1/en
Priority to BG106678A priority patent/BG106678A/en
Priority to BG107266A priority patent/BG107266A/en
Priority to IS6626A priority patent/IS6626A/en
Priority to IN1649MU2002 priority patent/IN2002MU01649A/en
Priority to MA27003A priority patent/MA26931A1/en
Priority to NO20030416A priority patent/NO324220B1/en
Priority to HR20030061A priority patent/HRP20030061A2/en
Priority to EC2003004454A priority patent/ECSP034454A/en
Priority to ZA200301457A priority patent/ZA200301457B/en
Priority to HK03102607A priority patent/HK1050367A1/en
Priority to HK03108198A priority patent/HK1055954A1/en
Priority to US10/753,199 priority patent/US7176311B2/en
Priority to IN80MU2005 priority patent/IN2005MU00080A/en
Priority to HK05102106A priority patent/HK1069577A1/en
Priority to HK05110418A priority patent/HK1078574A1/en
Priority to IN264MU2006 priority patent/IN2006MU00264A/en
Priority to US11/463,931 priority patent/US20060293347A1/en
Priority to IN567MU2007 priority patent/IN2007MU00567A/en
Priority to CR10191A priority patent/CR10191A/en
Priority to US12/469,311 priority patent/US20100035891A1/en
Ceased legal-status Critical Current

Links

GB0018656A 1999-10-11 2000-07-28 Pharmaceutically active compounds Ceased GB0018656D0 (en)

Priority Applications (113)

Application Number Priority Date Filing Date Title
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
TW089118861A TWI265925B (en) 1999-10-11 2000-09-14 Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
US09/685,080 US6677335B1 (en) 1999-10-11 2000-10-06 Pharmaceutically active compounds
MYPI20004712A MY130319A (en) 1999-10-11 2000-10-09 Pharmaceutically active compounds
PH12000002783A PH12000002783B1 (en) 1999-10-11 2000-10-09 Pyrazolo[4,3-D] pyrimidine derivatives.
EG20001281A EG24411A (en) 1999-10-11 2000-10-09 Pharmaceutically active compounds
GT200000171A GT200000171A (en) 1999-10-11 2000-10-10 PHARMACEUTICALLY ACTIVE COMPOUNDS.
TNTNSN00199A TNSN00199A1 (en) 1999-10-11 2000-10-10 PYRAZOLO [4,3-d] PYRIMIDINES-7-ONES PHARMACEUTICALLY ACTIVE, THEIR PREPARATION AND DRUGS CONTAINING THEM
PA20008504501A PA8504501A1 (en) 1999-10-11 2000-10-10 PHARMACEUTICALLY ACTIVE COMPOUNDS
AU76784/00A AU779065B2 (en) 1999-10-11 2000-10-11 Pyrazolo (4,3-D) pyrimidine derivatives
CO00077467A CO5251477A1 (en) 1999-10-11 2000-10-11 PHARMACEUTICALLY ACTIVE COMPOUNDS
DE60016615T DE60016615T2 (en) 1999-10-11 2000-10-11 Pyrazolo [4,3-D] PYRIMIDINE DERIVATIVES
DK00966347T DK1220856T3 (en) 1999-10-11 2000-10-11 Pyrazolo [4,3-d] pyrimidine derivatives
PL00357536A PL357536A1 (en) 1999-10-11 2000-10-11 Pyrazolo `4,3-d! pyrimidine derivatives
ES00966347T ES2232502T3 (en) 1999-10-11 2000-10-11 DERIVATIVES OF PIRAZOLO (4,3-D) PYRIMIDINE.
EEP200200195A EE05181B1 (en) 1999-10-11 2000-10-11 P rasolo [4,3-d] pyrimidine derivatives, pharmaceutical compositions containing them, their use and methods for their preparation
CA002387357A CA2387357C (en) 1999-10-11 2000-10-11 Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
EA200200337A EA004982B1 (en) 1999-10-11 2000-10-11 PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES
HU0203450A HUP0203450A3 (en) 1999-10-11 2000-10-11 Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use
GEAP20005578A GEP20033068B (en) 1999-10-11 2000-10-11 Processes for Preparation of Pyrazolo[4,3-d]Pyrimidin-7-Ones-3-Pyridylsulphonyl Compounds and Intermediates Thereof
DZ003220A DZ3220A1 (en) 1999-10-11 2000-10-11 PHARMACEUTICALLY ACTIVE COMPOUNDS
PCT/IB2000/001457 WO2001027113A2 (en) 1999-10-11 2000-10-11 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
JP2001530331A JP3834236B2 (en) 1999-10-11 2000-10-11 Pyrazolo [4,3-D] pyrimidine derivatives
BR0014698-6A BR0014698A (en) 1999-10-11 2000-10-11 Pyrazolo [4,3-d] pyrimidine derivatives
APAP/P/2002/002456A AP1238A (en) 1999-10-11 2000-10-11 Pyrazolo[4,3-D] pyrimidine derivatives.
OA1200200104A OA12061A (en) 1999-10-11 2000-10-11 Pyrazolo Ä4,3-DÜpyrimidine derivatives.
SV2000000195A SV2002000195A (en) 1999-10-11 2000-10-11 PHARMACEUTICALLY ACTIVE COMPOUNDS REF. PCS10342 AFAE / BB
CNB2004100384099A CN100383141C (en) 1999-10-11 2000-10-11 Pyrazolo [4,3-d] pyrimidine derivatives
KR1020027004643A KR100549152B1 (en) 1999-10-11 2000-10-11 Pyrazolo[4,3-D] pyrimidine derivatives.
SK460-2002A SK4602002A3 (en) 1999-10-11 2000-10-11 Pyrazolo [4,3-d]pyrimidine derivatives, method for producing thereof and their use
PE2000001090A PE20010737A1 (en) 1999-10-11 2000-10-11 PIRAZOLO [4,3-d] -PYRIMIDIN-7-ONA AS INHIBITORS OF 3`, 5'-GUANOSINMONOPHOSPHATE CYCLIC PHOSPHODIESTERASE
AT00966347T ATE284404T1 (en) 1999-10-11 2000-10-11 PYRAZOLO(4,3-D)PYRIMIDINE DERIVATIVES
IL14902600A IL149026A0 (en) 1999-10-11 2000-10-11 PYRAZOLO [4, 3-d] PYRIMIDINE DERIVATIVES
NZ518078A NZ518078A (en) 1999-10-11 2000-10-11 Pyrazolo[4,3-d]pyrimidine derivatives
CNB2005100625827A CN100378100C (en) 1999-10-11 2000-10-11 Pyrazolo(4,3-d)pyrimidine derivatives
TR2002/00989T TR200200989T2 (en) 1999-10-11 2000-10-11 Pharmaceutically active compounds.
GEAP20006408A GEP20033142B (en) 1999-10-11 2000-10-11 Pyrazolo (4,3-D) Pyrimidine Derivatives
YUP-314/02A RS50476B (en) 1999-10-11 2000-10-11 Pyrazolo (4,3-d) pyrimidine derivatives
CZ20021158A CZ20021158A3 (en) 1999-10-11 2000-10-11 Pyrazolo[4,3-d]pyrimidine derivatives
CNB008151954A CN1204138C (en) 1999-10-11 2000-10-11 Pyrazolo [4,3-d] pyrimidine derivs.
PT00966347T PT1220856E (en) 1999-10-11 2000-10-11 PHARMACEUTICALLY ACTIVE COMPOUNDS
SI200030593T SI1220856T1 (en) 1999-10-11 2000-10-11 Pyrazolo(4,3-d)pyrimidine derivatives
EP00966347A EP1220856B1 (en) 1999-10-11 2000-10-11 Pyrazolo[4,3-d]pyrimidine derivatives
AU7269001A AU7269001A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
CA002417264A CA2417264C (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
AT01951842T ATE286901T1 (en) 2000-07-28 2001-07-18 CRYSTALLINE THERAPEUTIC AGENT
KR20037001202A KR100457937B1 (en) 2000-07-28 2001-07-18 Crystalline Therapeutic Agent
EA200300079A EA004681B1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
CNB018133924A CN1207297C (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
BR0112734-9A BR0112734A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
MXPA03000856 MX233602B (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent.
NZ523226A NZ523226A (en) 2000-07-28 2001-07-18 Crystalline form of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine
PCT/IB2001/001280 WO2002010171A1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
JP2002515900A JP2004505087A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
ES01951842T ES2231521T3 (en) 2000-07-28 2001-07-18 CRYSTAL THERAPEUTIC AGENT.
EP01951842A EP1305314B1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
GE5062A GEP20053494B (en) 2000-07-28 2001-07-18 Crystalline Therapeutic Agent
IL15322601A IL153226A0 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
HU0302982A HUP0302982A3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
PL01365133A PL365133A1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
OA1200300008A OA12337A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent.
CZ2003126A CZ2003126A3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic formulation
UA2003010715A UA72631C2 (en) 2000-07-28 2001-07-18 Cryslalline therapeutical agent
DE60108398T DE60108398T2 (en) 2000-07-28 2001-07-18 CRYSTALLINE THERAPEUTIC AGENT
SK57-2003A SK572003A3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
PT01951842T PT1305314E (en) 2000-07-28 2001-07-18 CRYSTAL THERAPEUTIC AGENT
SI200130283T SI1305314T1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
EEP200300045A EE200300045A (en) 2000-07-28 2001-07-18 Crystalline drug substance
AU2001272690A AU2001272690B2 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
DZ013364A DZ3364A1 (en) 2000-07-28 2001-07-18 CRYSTALLINE THERAPEUTIC AGENT
YU4703A YU4703A (en) 2000-07-28 2001-07-18 Cristalline therapeutic agent
DK01951842T DK1305314T3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
PE2001000746A PE20020277A1 (en) 2000-07-28 2001-07-24 POLYMORPH 1- {6-ETHOXY-5- [3-ETHYL-6,7-DIHYDRO-2- (2-METOXYETHYL) -7-OXO-2H-PYRAZOLO [4,3-d] PYRIMIDIN-5-IL] - 3-PYRIDYLSULFONIL} -4-ETHYLPIPERAZINE
MYPI20013530A MY117831A (en) 2000-07-28 2001-07-25 Crystalline therapeutic agent
US09/915,705 US6420557B1 (en) 2000-07-28 2001-07-26 Crystalline therapeutic agent
PH12001001922A PH12001001922B1 (en) 2000-07-28 2001-07-26 Crystalline therapeutic agent.
UY26854A UY26854A1 (en) 2000-07-28 2001-07-26 CRYSTAL THERAPEUTIC AGENT
DO2001000217A DOP2001000217A (en) 2000-07-28 2001-07-26 CRYSTAL THERAPEUTIC AGENT
APAP/P/2001/002234A AP1400A (en) 2000-07-28 2001-07-26 Crystalline therapeutic agent.
ARP010103576A AR032628A1 (en) 2000-07-28 2001-07-26 POLYMORPH COMPOUND 1- {6-ETOXI-5- [3-ETIL-6,7-DIHYDRO-2- (2-METOXYETHYL) -7-OXO-2H-PIRAZOLO [4,3-D] PIRIMIDIN-5-IL ] -3-PIRIDILSULFONIL} -4-ETILPIPERAZINA
PA20018523501A PA8523501A1 (en) 2000-07-28 2001-07-27 CRYSTAL THERAPEUTIC AGENT
TNTNSN01112A TNSN01112A1 (en) 2000-07-28 2001-07-27 CRYSTALLINE THERAPEUTIC AGENT
SV2001000570A SV2001000570A (en) 2000-07-28 2001-07-27 CRYSTAL THERAPEUTIC AGENT REF. PCS22011AFAE / BB
TW090118441A TWI285643B (en) 2000-07-28 2001-07-27 A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine and a process for preparing the same
CU20020060A CU23198A3 (en) 1999-10-11 2002-03-21 PHARMACEUTICALLY ACTIVE COMPOUNDS
IS6320A IS2181B (en) 1999-10-11 2002-03-21 Pyrazolo [4,3-d] pyrimidine derivatives
IN385MU2002 IN2002MU00385A (en) 1999-10-11 2002-03-28
MA26586A MA26825A1 (en) 1999-10-11 2002-04-05 PYRAZOLO [4,3-D] PYRIMIDINE DERIVATIVES
CR6617A CR6617A (en) 1999-10-11 2002-04-08 PYRAZOL DERIVATIVES (4.3D) PYRIMIDINE
IL149026A IL149026A (en) 1999-10-11 2002-04-08 5-[2-ALKOXY-5-[(4-ALKYLPIPERAZIN-1-YL)SULFONYL]PYRIDIN-3-YL]-3-ALKYL-1,6-(OR 2,6)-DIHYDRO-1-(OR 2)-SUBSTITUTED PYRAZOLO [4,3-d] PYRIMIDIN-7-ONE DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME NOVEL INTERMEDIATES THEREFOR AND THEIR PREPARATION
NO20021694A NO322856B1 (en) 1999-10-11 2002-04-10 Pyrazolo [4,3-d] pyrimidine
MXPA02003627 MX228340B (en) 1999-10-11 2002-04-10 Pyrazolo[4,3-D] pyrimidine derivatives.
HR20020317A HRP20020317B1 (en) 1999-10-11 2002-04-11 Pharmaceutically active compounds
BG106678A BG106678A (en) 1999-10-11 2002-05-09 PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES
BG107266A BG107266A (en) 2000-07-28 2002-11-12 Crystalline therapeutic agent
IS6626A IS6626A (en) 2000-07-28 2002-11-18 Crystalline treatment agent
IN1649MU2002 IN2002MU01649A (en) 2000-07-28 2002-11-20
MA27003A MA26931A1 (en) 2000-07-28 2003-01-20 CRYSTALLINE THERAPEUTIC AGENT.
NO20030416A NO324220B1 (en) 2000-07-28 2003-01-27 Process for preparing a polymorph
HR20030061A HRP20030061A2 (en) 2000-07-28 2003-01-28 Crystalline therapeutic agent
EC2003004454A ECSP034454A (en) 2000-07-28 2003-01-28 CRYSTAL THERAPEUTIC AGENT
ZA200301457A ZA200301457B (en) 2000-07-28 2003-02-24 Crystalline therapeutic agent.
HK03102607A HK1050367A1 (en) 1999-10-11 2003-04-10 Pharmaceutically active compounds.
HK03108198A HK1055954A1 (en) 2000-07-28 2003-11-12 Crystalline therapeutic agent.
US10/753,199 US7176311B2 (en) 1999-10-11 2004-01-06 Process for preparing pharmaceutically active compounds
IN80MU2005 IN2005MU00080A (en) 1999-10-11 2005-01-28
HK05102106A HK1069577A1 (en) 1999-10-11 2005-03-11 Pyrazolo [4,3-D] pyrimidine derivatives
HK05110418A HK1078574A1 (en) 1999-10-11 2005-11-18 Pyrazolo [4,3-D] pyrimidine derivatives
IN264MU2006 IN2006MU00264A (en) 1999-10-11 2006-03-08
US11/463,931 US20060293347A1 (en) 1999-10-11 2006-08-11 Pharmaceutically active compounds
IN567MU2007 IN2007MU00567A (en) 1999-10-11 2007-04-19
CR10191A CR10191A (en) 1999-10-11 2008-08-08 DERIVATIVES OF PIRAZOLO (3,4D) PYRIMIDINE. (DIVISIONAL)
US12/469,311 US20100035891A1 (en) 1999-10-11 2009-05-20 Pharmaceutically Active Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
GB0018656D0 true GB0018656D0 (en) 2000-09-13

Family

ID=9896611

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0018656A Ceased GB0018656D0 (en) 1999-10-11 2000-07-28 Pharmaceutically active compounds

Country Status (1)

Country Link
GB (1) GB0018656D0 (en)

Similar Documents

Publication Publication Date Title
EG24411A (en) Pharmaceutically active compounds
GB9924020D0 (en) Pharmaceutically active compounds
IL146117A0 (en) New pharmaceutically active compounds
GB9823101D0 (en) Pharmaceutically active compounds
SG115489A1 (en) Pharmaceutically active morpholinol
GB9823102D0 (en) Pharmaceutically active compounds
HK1054031A1 (en) Pharmaceutically active pyrrolidine derivatives
GB0107751D0 (en) Pharmaceutically active compounds
GB0105893D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
AU6036100A (en) New pharmaceutically active compounds
GB0019272D0 (en) Pharmaceutical compounds
GB0017822D0 (en) Pharmaceutically active compound
GB0024318D0 (en) Pharmaceutical compounds
GB0018656D0 (en) Pharmaceutically active compounds
GB0018660D0 (en) Pharmaceutically active compounds
GB0007345D0 (en) Pharmaceutically active compounds
GB0005366D0 (en) Pharmaceutical compounds
GB9926630D0 (en) Pharmacologically active compounds
GB0219897D0 (en) Pharmaceutically active compounds
GB0106562D0 (en) Pharmaceutically active compounds
GB0106561D0 (en) Pharmaceutically active compounds
GB0106617D0 (en) Pharmaceutically active compounds
GB0106629D0 (en) Pharmaceutically active compounds
GB0106651D0 (en) Pharmaceutically active compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)